The U.S. Food and Drug Administration is warning consumers to discard cheeses from Estrella Family Creamery of Montesano, Wash., because they may be contaminated with Listeria monocytogenes. Environmental samples and one product sample collected by the FDA during an August 2010 inspection at the facility have tested positive for L. mono.

The U.S. Department of Justice, on behalf of the U.S. Food and Drug Administration, has filed a complaint for permanent injunction against Scenic View Dairy of Hamilton, Mich., its president, and three of its managers alleging that they sold dairy cows for human consumption that contained illegal drug residues in edible tissues.

The U.S. Food and Drug Administration today launched an innovative performance management system designed to advance the President’s commitment to transparency, public participation, and collaboration in the work of government.

The U.S. Food and Drug Administration is warning consumers not to take TimeOut Capsules because it contains an active drug ingredient that can dangerously lower blood pressure. The product is marketed as a dietary supplement for sexual enhancement.

The Honourable Leona Aglukkaq, Minister of Health, today accepted the recommendations on Multiple Sclerosis (MS) research recently presented to her by Canadian Institutes of Health Research (CIHR) President Dr. Alain Beaudet. These recommendations are based on a thorough review of the current state of science conducted at an August 26, 2010, meeting of leading North American MS experts.

As children head back to the classroom, Health Canada is reminding parents of the importance of allergy awareness when packing lunches for their children. Severe allergic reactions can occur quickly and without warning, and some foods can be life-threatening to allergic children.

Health Canada is again warning parents and caregivers against using hammocks designed for infants and young children due to the potential suffocation hazard posed by these products. The product's inclined sleeping surface increases the risk of infants rolling and becoming wedged in a position where they can no longer breathe.

Health Canada is informing Canadians that Novo Nordisk Canada Inc. has agreed to voluntarily recall two lots (YW60335 and YW60351) of their product, GlucaGen Hypokit (DIN 02333627) currently available on the Canadian market.